Return On Equity in % of Eloxx Pharmaceuticals, Inc. from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Return On Equity history and change rate from Q1 2012 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2023 was 248 %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2022 was 6.73K %.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2021 was -270 %, a 40.4% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Return On Equity for 2020 was -192 %, a 61.8% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Eloxx Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 248 +790 01 Jul 2023 30 Sep 2023
Q2 2023 544 +801 01 Apr 2023 30 Jun 2023
Q1 2023 -4.98K -4.72K -1826% 01 Jan 2023 31 Mar 2023
Q4 2022 6.73K +7K 01 Oct 2022 31 Dec 2022
Q3 2022 -542 -261 -93% 01 Jul 2022 30 Sep 2022
Q2 2022 -257 +78 +23.3% 01 Apr 2022 30 Jun 2022
Q1 2022 -259 -16.1 -6.62% 01 Jan 2022 31 Mar 2022
Q4 2021 -270 -77.7 -40.4% 01 Oct 2021 31 Dec 2021
Q3 2021 -281 -117 -71.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -335 -190 -131% 01 Apr 2021 30 Jun 2021
Q1 2021 -243 -113 -86.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -192 -73.5 -61.8% 01 Oct 2020 31 Dec 2020
Q3 2020 -164 -44 -36.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -145 -32.8 -29.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -130 -22.8 -21.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -119 -6.45 -5.73% 01 Oct 2019 31 Dec 2019
Q3 2019 -120 -0.15 -0.13% 01 Jul 2019 30 Sep 2019
Q2 2019 -112 +37.3 +25% 01 Apr 2019 30 Jun 2019
Q1 2019 -107 +171 +61.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -112 +189 +62.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -120 +497 +80.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -149 +281 +65.3% 01 Apr 2018 30 Jun 2018
Q1 2018 -278 01 Jan 2018 31 Mar 2018
Q4 2017 -301 01 Oct 2017 31 Dec 2017
Q3 2017 -617 01 Jul 2017 30 Sep 2017
Q2 2017 -431 01 Apr 2017 30 Jun 2017
Q1 2015 -130 -2.67 -2.09% 01 Jan 2015 31 Mar 2015
Q4 2014 -139 +6.55 +4.49% 01 Oct 2014 31 Dec 2014
Q3 2014 -74.9 +141 +65.3% 01 Jul 2014 30 Sep 2014
Q2 2014 -78.3 +138 +63.8% 01 Apr 2014 30 Jun 2014
Q1 2014 -128 +77.5 +37.8% 01 Jan 2014 31 Mar 2014
Q4 2013 -146 +45.2 +23.7% 01 Oct 2013 31 Dec 2013
Q3 2013 -216 -34.8 -19.2% 01 Jul 2013 30 Sep 2013
Q2 2013 -217 -79.8 -58.4% 01 Apr 2013 30 Jun 2013
Q1 2013 -205 -45.6 -28.6% 01 Jan 2013 31 Mar 2013
Q4 2012 -191 01 Oct 2012 31 Dec 2012
Q3 2012 -181 01 Jul 2012 30 Sep 2012
Q2 2012 -137 01 Apr 2012 30 Jun 2012
Q1 2012 -160 01 Jan 2012 31 Mar 2012

Eloxx Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 6.73K +7K 01 Jan 2022 31 Dec 2022
2021 -270 -77.7 -40.4% 01 Jan 2021 31 Dec 2021
2020 -192 -73.5 -61.8% 01 Jan 2020 31 Dec 2020
2019 -119 -6.45 -5.73% 01 Jan 2019 31 Dec 2019
2018 -112 +189 +62.7% 01 Jan 2018 31 Dec 2018
2017 -302 -28.8 -10.6% 01 Jan 2017 31 Dec 2017
2016 -273 -203 -289% 01 Jan 2016 31 Dec 2016
2015 -70.1 +8.24 +10.5% 01 Jan 2015 31 Dec 2015
2014 -78.3 +138 +63.8% 01 Jul 2013 30 Jun 2014
2013 -217 -79.8 -58.4% 01 Jul 2012 30 Jun 2013
2012 -137 01 Jul 2011 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.